Advanced search
Publication Cover
Epigenetics Volume 17, 2022 - Issue 8
Submit an article Journal homepage
2,067
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Disease-related blood-based differential methylation in cystic fibrosis and its representation in lung cancer revealed a regulatory locus in PKP3 in lung epithelial cells

Esther Schamschulaa Department of Biosciences, University of Salzburg, Salzburg, AustriaORCID Iconhttps://orcid.org/0000-0002-8874-1713View further author information
ORCID Icon,
Angelika Lahnsteinera Department of Biosciences, University of Salzburg, Salzburg, AustriaView further author information
,
Yassen Assenovb Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, GermanyORCID Iconhttps://orcid.org/0000-0002-6992-2092View further author information
ORCID Icon,
Wolfgang Hagmannb Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, GermanyView further author information
,
Nadja Zaborskyc Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria;d Cancer ClusterSalzburg, Salzburg, AustriaView further author information
,
Markus Wiedersteina Department of Biosciences, University of Salzburg, Salzburg, AustriaView further author information
,
Anna Strobla Department of Biosciences, University of Salzburg, Salzburg, AustriaView further author information
,
Frauke Stankee Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hannover, Germany;f Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover Medical School, Hannover, GermanyView further author information
,
Thomas Muleyg Translational Research Unit, Thoraxklinik Heidelberg, University of Heidelberg, Germany;h Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyView further author information
,
Christoph Plassb Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany;h Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyView further author information
,
Burkhard Tümmlere Clinical Research Group, Clinic for Pediatric Pneumology, Allergology and Neonatology, Hannover, Germany;f Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover Medical School, Hannover, GermanyView further author information
&
Angela Rischa Department of Biosciences, University of Salzburg, Salzburg, Austria;b Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany;d Cancer ClusterSalzburg, Salzburg, Austria;h Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8026-5505View further author information
ORCID Icon show all
Pages 837-860 | Received 21 Mar 2021, Accepted 21 Jul 2021, Published online: 20 Aug 2021

References

  • Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–1073.
  • Warwick WJ. The incidence of cystic fibrosis in Caucasian populations. Helv Paediatr Acta. 1978;33(2):117–125.
  • Stanke F, Tümmler B. Classification of CFTR mutation classes. Lancet Respir Med. 2016;4(8):e36.
  • Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci. 2017;74(1):129–140.
  • Roesch EA, Nichols DP, Chmiel JF. Inflammation in cystic fibrosis: an update. Pediatr Pulmonol. 2018;53(S3):S30–S50.
  • Mekus F, Ballmann M, Bronsveld I, et al. Categories of ΔF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2001;3(4):277–293.
  • Brownell JN, Bashaw H, Stallings VA. Growth and Nutrition in Cystic Fibrosis. Semin Respir Crit Care Med. 2019;40(6):775–791.
  • Cantin AM, Hartl D, Konstan MW, et al. Inflammation in cystic fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros. 2015;14(4):419–430.
  • Cutting GR. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat Rev Genet. 2015;16(1):45–56.
  • Gong J, Wang F, Xiao B, et al. Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci. PLoS Genet. 2019;15(2):e1008007.
  • Shanthikumar S, Neeland MN, Saffery R, et al. Gene modifiers of cystic fibrosis lung disease: a systematic review. Pediatr Pulmonol. 2019;54(9):1356–1366.
  • Stanke F, Hector A, Hedtfeld S, et al. An informative intragenic microsatellite marker suggests the IL-1 receptor as a genetic modifier in cystic fibrosis. Eur Respir J. 2017;50(6):6.
  • Bolund ACS, Starnawska A, Miller MR, et al. Lung function discordance in monozygotic twins and associated differences in blood DNA methylation. Clin Epigenetics. 2017;9(1):132.
  • Collaco JM, Blackman SM, McGready J, et al. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802–807.e801-803.
  • Tan Q, Christiansen L, von Bornemann Hjelmborg J, et al. Twin methodology in epigenetic studies. J Exp Biol. 2015;218(Pt 1):134–139.
  • Xiang Z, Yang Y, Chang C, et al. The epigenetic mechanism for discordance of autoimmunity in monozygotic twins. J Autoimmun. 2017;83:43–50.
  • Generali E, Ceribelli A, Stazi MA, et al. Lessons learned from twins in autoimmune and chronic inflammatory diseases. J Autoimmun. 2017;83:51–61.
  • Gomez-Cabrero D, Almgren M, Sjöholm LK, et al. High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis. Genome Med. 2016;8(1):124.
  • Hwang JY, Lee HJ, Go MJ, et al. Genome-wide methylation analysis identifies ELOVL5 as an epigenetic biomarker for the risk of type 2 diabetes mellitus. Sci Rep. 2018;8(1):14862.
  • Roos L, van Dongen J, Bell CG, et al. Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs. Clin Epigenetics. 2016;8(1):7.
  • Schamschula E, Hagmann W, Assenov Y, et al. Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins. J Cyst Fibros. 2021;20(1):149–153.
  • Fasanelli F, Baglietto L, Ponzi E, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015;6(1):10192.
  • Wrage M, Hagmann W, Kemming D, et al. Identification of HERC5 and its potential role in NSCLC progression. Int J Cancer. 2015;136(10):2264–2272.
  • Baglietto L, Ponzi E, Haycock P, et al. DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. Int J Cancer. 2017;140(1):50–61.
  • Bergougnoux A, Claustres M, De Sario A. Nasal epithelial cells: a tool to study DNA methylation in airway diseases. Epigenomics. 2015;7(1):119–126.
  • Farré P, Jones MJ, Meaney MJ, et al. Concordant and discordant DNA methylation signatures of aging in human blood and brain. Epigenetics Chromatin. 2015;8(1):19.
  • Houseman EA, Kim S, Kelsey KT, et al. DNA Methylation in Whole Blood: uses and Challenges. Curr Environ Health Rep. 2015;2(2):145–154.
  • Huang Y-T, Chu S, Loucks EB, et al. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood. Epigenetics. 2016;11(3):227–236.
  • Um SW, Kim Y, Lee BB, et al. Genome-wide analysis of DNA methylation in bronchial washings. Clin Epigenetics. 2018;10(1):65.
  • Choi J, Lyons DB, Kim MY, et al. DNA Methylation and Histone H1 Jointly Repress Transposable Elements and Aberrant Intragenic Transcripts. Mol Cell. 2020;77(2):310–323.e317.
  • Pfeifer GP. Defining Driver DNA Methylation Changes in Human Cancer. Int J Mol Sci. 2018;19(4):1166.
  • Tirado-Magallanes R, Rebbani K, Lim R, et al. Whole genome DNA methylation: beyond genes silencing. Oncotarget. 2017;8(3):5629–5637.
  • Wolff F, Leisch M, Greil R, et al. The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation. Cell Commun Signal. 2017;15(1):13.
  • Calle-Fabregat CDL, Morante-Palacios O, Ballestar E. Understanding the Relevance of DNA Methylation Changes in Immune Differentiation and Disease. Genes (Basel). 2020;11(1):110.
  • Ciechomska M, Roszkowski L, Maslinski W. DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis. Cells. 2019;8(9):953.
  • Hedrich CM, Mäbert K, Rauen T, et al. DNA methylation in systemic lupus erythematosus. Epigenomics. 2017;9(4):505–525.
  • Saradna A, Do DC, Kumar S, et al. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14.
  • Hattori N, Ushijima T. Analysis of DNA Methylation in Tissues Exposed to Inflammation. Methods Mol Biol. 2018;1725:185–199.
  • Scott M, De Sario A. DNA methylation changes in cystic fibrosis: cause or consequence? Clin Genet. 2020;98(1):3–9.
  • Somineni HK, Venkateswaran S, Kilaru V, et al. Blood-Derived DNA Methylation Signatures of Crohn’s Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019;156(8):2254–2265.e2253.
  • Sun S, Barreiro LB. The epigenetically-encoded memory of the innate immune system. Curr Opin Immunol. 2020;65:7–13.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
  • Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2017;9(6):7204–7218.
  • Poetsch AR. The genomics of oxidative DNA damage, repair, and resulting mutagenesis. Comput Struct Biotechnol J. 2020;18:207–219.
  • Bouchard MJ, Navas-Martin S. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. Cancer Lett. 2011;305(2):123–143.
  • Hattori N, Ushijima T. Epigenetic impact of infection on carcinogenesis: mechanisms and applications. Genome Med. 2016;8(1). DOI:10.1186/s13073-016-0267-2
  • Mitra A, MacIntyre DA, Marchesi JR, et al. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58.
  • Maeda M, Moro H, Ushijima T. Mechanisms for the induction of gastric cancer by Helicobacter pylori infection: aberrant DNA methylation pathway. Gastric Cancer. 2017;20(Suppl 1):8–15.
  • Takeshima H, Ushijima T. Accumulation of genetic and epigenetic alterations in normal cells and cancer risk. NPJ Precis Oncol. 2019;3(1):7.
  • Eyvazi S, Vostakolaei MA, Dilmaghani A, et al. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog. 2020;141:104019.
  • Nakagawa T, Matsusaka K, Misawa K, et al. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes. Int J Cancer. 2020;146(9):2460–2474.
  • Mur LA, Huws SA, Cameron SJ, et al. Lung cancer: a new frontier for microbiome research and clinical translation. Ecancermedicalscience. 2018;12:866.
  • Dong J, Ma Q. Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes. Nanotoxicology. 2019;13(9):1244–1274.
  • Husebø GR, Nielsen R, Hardie J, et al. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. Respir Med. 2019;152:81–88.
  • Hata A, Nakajima T, Matsusaka K, et al. A low DNA methylation epigenotype in lung squamous cell carcinoma and its association with idiopathic pulmonary fibrosis and poorer prognosis. Int J Cancer. 2020;146(2):388–399.
  • Parris BA, O’Farrell HE, Fong KM, et al. Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis. J Thorac Dis. 2019;11(Suppl 17):S2155–s2172.
  • Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995;332(8):494–499.
  • Zhang Z, Wang J, He J, et al. Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population. PLoS ONE. 2013;8(10):e77723.
  • Dong Y, Zhou L, Zhao D, et al. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis. Jpn J Clin Oncol. 2020;50(6):701–711.
  • Albino D, Longoni N, Curti L, et al. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features. Cancer Res. 2012;72(11):2889–2900.
  • Jäger B, Klatt D, Plappert L, et al. CXCR4/MIF axis amplifies tumor growth and epithelial-mesenchymal interaction in non-small cell lung cancer. Cell Signal. 2020;73:109672.
  • O’Leary K, Shia A, Schmid P. Epigenetic Regulation of EMT in Non-Small Cell Lung Cancer. Curr Cancer Drug Targets. 2018;18(1):89–96.
  • Warzecha CC, Carstens RP. Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol. 2012;22(5–6):417–427.
  • Wright FA, Strug LJ, Doshi VK, et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet. 2011;43(6):539–546.
  • He Q, Wang L, Zhang J, et al. CYP2E1 and GSTM1 gene polymorphisms, environmental factors, and the susceptibility to lung cancer. J Clin Lab Anal. 2018;32(6):e22403.
  • Yu P, Kusuma JD, Suarez MAR, et al. Lung cancer susceptibility from GSTM1 deletion and air pollution with smoking status: a meta-prediction of worldwide populations. Oncotarget. 2018;9(57):31120–31132.
  • Grieshober L, Graw S, Barnett MJ, et al. AHRR methylation in heavy smokers: associations with smoking, lung cancer risk, and lung cancer mortality. BMC Cancer. 2020;20(1):905.
  • Park KH, Lo Han SG, Whang YM, et al. Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet. 2006;169(1):39–44.
  • Risch A, Wikman H, Thiel S, et al. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics. 2001;11(9):757–764.
  • Timofeeva MN, Hung RJ, Rafnar T, et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012;21(22):4980–4995.
  • Assenov Y, Müller F, Lutsik P, et al. Comprehensive Analysis of DNA Methylation Data with RnBeads. Nat Methods. 2014;11(11):1138–1140.
  • Price ME, Cotton AM, Lam LL, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics Chromatin. 2013;6(1):4.
  • Kurdyukov S, Bullock M. DNA Methylation Analysis: choosing the Right Method. Biology (Basel). 2016;5(1):3.
  • Reinius LE, Acevedo N, Joerink M, et al. Differential DNA Methylation in Purified Human Blood Cells: implications for Cell Lineage and Studies on Disease Susceptibility. PLoS ONE. 2012;7(7):e41361.
  • Díez-Villanueva A, Mallona I, Peinado MA. Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer. Epigenetics Chromatin. 2015;8(1):22.
  • Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol. 2010;28(8):817–825.
  • Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473(7345):43–49.
  • Euskirchen GM, Rozowsky JS, Wei CL, et al. Mapping of transcription factor binding regions in mammalian cells by ChIP: comparison of array- and sequencing-based technologies. Genome Res. 2007;17(6):898–909.
  • Hudson ME, Snyder M. High-throughput methods of regulatory element discovery. Biotechniques. 2006;41(6): 673, 675, 677 passim.
  • Grana O, Lopez-Fernandez H, Fdez-Riverola F, et al. Bicycle: a bioinformatics pipeline to analyze bisulfite sequencing data. Bioinformatics. 2018;34(8):1414–1415.
  • Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13(1):86.
  • Hu H, Li B, Duan S. The Alteration of Subtelomeric DNA Methylation in Aging-Related Diseases. Front Genet. 2019;9:697.
  • Elborn JS. Cystic fibrosis. Lancet. 2016;388(10059):2519–2531.
  • Bergman Y, Cedar H. DNA methylation dynamics in health and disease. Nat Struct Mol Biol. 2013;20(3):274–281.
  • Kaminsky ZA, Tang T, Wang S-C, et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet. 2009;41(2):240–245.
  • Van Baak TE, Coarfa C, Dugué P-A, et al. Epigenetic supersimilarity of monozygotic twin pairs. Genome Biol. 2018;19(1):2.
  • Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax. 2009;64(1):81–88.
  • Holliday R, Pugh J. DNA modification mechanisms and gene activity during development. Science. 1975;187(4173):226–232.
  • Levy H, Kalish LA, Huntington I, et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol. 2007;42(3):256–262.
  • Terry MB, Delgado-Cruzata L, Vin-Raviv N, et al. DNA methylation in white blood cells: association with risk factors in epidemiologic studies. Epigenetics. 2011;6(7):828–837.
  • Guida F, Sandanger TM, Castagné R, et al. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum Mol Genet. 2015;24(8):2349–2359.
  • Teschendorff AE, Yang Z, Wong A, et al. Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer. JAMA Oncol. 2015;1(4):476–485.
  • Zhou G, Yang L, Gray A, et al. The role of desmosomes in carcinogenesis. Onco Targets Ther. 2017;10:4059–4063.
  • Bibikova M, Barnes B, Tsan C, et al. High density DNA methylation array with single CpG site resolution. Genomics. 2011;98(4):288–295.
  • Doi A, Park IH, Wen B, et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009;41(12):1350–1353.
  • Irizarry RA, Ladd-Acosta C, Wen B, et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet. 2009;41(2):178–186.
  • Ziller MJ, Gu H, Müller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500(7463):477–481.
  • Neri F, Rapelli S, Krepelova A, et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature. 2017;543(7643):72–77.
  • Yang X, Han H, De Carvalho DD, et al. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell. 2014;26(4):577–590.
  • Arechederra M, Daian F, Yim A, et al. Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer. Nat Commun. 2018;9(1):3164.
  • Gu J, Stevens M, Xing X, et al. Mapping of Variable DNA Methylation Across Multiple Cell Types Defines a Dynamic Regulatory Landscape of the Human Genome. G3 (Bethesda). 2016;6(4):973–986.
  • Arzate-Mejía RG, Recillas-Targa F, Corces VG. Developing in 3D: the role of CTCF in cell differentiation. Development. 2018;145(6):dev137729.
  • Herold M, Bartkuhn M, Renkawitz R. CTCF: insights into insulator function during development. Development. 2012;139(6):1045–1057.
  • Ruiz-Velasco M, Kumar M, Lai MC, et al. CTCF-Mediated Chromatin Loops between Promoter and Gene Body Regulate Alternative Splicing across Individuals. Cell Syst. 2017;5(6):628–637.e626.
  • Ambrosi C, Manzo M, Baubec T. Dynamics and Context-Dependent Roles of DNA Methylation. J Mol Biol. 2017;429(10):1459–1475.
  • Lévêque M, Le Trionnaire S, Del Porto P, et al. The impact of impaired macrophage functions in cystic fibrosis disease progression. J Cyst Fibros. 2017;16(4):443–453.
  • Barnes PJ. Cellular and molecular mechanisms of asthma and COPD. Clin Sci. 2017;131(13):1541–1558.
  • Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013;13(4):233–245.
  • Shields PG, Berman M, Brasky TM, et al. A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: a Focus on Inflammation. Cancer Epidemiol Biomarkers Prev. 2017;26(8):1175–1191.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
  • Strzelak A, Ratajczak A, Adamiec A, et al. Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: a Mechanistic Review. Int J Environ Res Public Health. 2018;15(5):1033.
  • Chaparro C, Keshavjee S. Lung transplantation for cystic fibrosis: an update. Expert Rev Respir Med. 2016;10(12):1269–1280.
  • Ranganathan SC, Hall GL, Sly PD, et al., & Australian Respiratory Early Surveillance Team for Cystic, F. Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis. What Have We Learned and What Should We Do about It? Am J Respir Crit Care Med. 2017;195(12):1567–1575. .
  • Li Y, Sun Z, Wu Y, et al. Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer. 2010;70(1):14–21.
  • Bronsveld I, Mekus F, Bijman J, et al. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of ΔF508 homozygous twins and siblings. J Clin Investig. 2001;108(11):1705–1715.
  • MacGregor AJ, Snieder H, Schork NJ, et al. Twins: novel uses to study complex traits and genetic diseases. Trends Genet. 2000;16(3):131–134.
  • Gentilini D, Garagnani P, Pisoni S, et al. Stochastic epigenetic mutations (DNA methylation) increase exponentially in human aging and correlate with X chromosome inactivation skewing in females. Aging (Albany NY). 2015;7(8):568–578.
  • Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128(4):683–692.
  • Bell JT, Tsai PC, Yang TP, et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 2012;8(4):e1002629.
  • Boks MP, Derks EM, Weisenberger DJ, et al. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS ONE. 2009;4(8):e6767.
  • Hannon E, Knox O, Sugden K, et al. Characterizing genetic and environmental influences on variable DNA methylation using monozygotic and dizygotic twins. PLoS Genet. 2018;14(8):e1007544.
  • Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.
  • Liu J, Morgan M, Hutchison K, et al. A study of the influence of sex on genome wide methylation. PLoS ONE. 2010;5(4):e10028.
  • Teschendorff AE, Menon U, Gentry-Maharaj A, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010;20(4):440–446.
  • Yet I, Tsai P-C, Castillo-Fernandez JE, et al. Genetic and environmental impacts on DNA methylation levels in twins. Epigenomics. 2016;8(1):105–117.
  • Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005;102(30):10604–10609.
  • Talens RP, Christensen K, Putter H, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell. 2012;11(4):694–703.
  • Artis D, Spits H. The biology of innate lymphoid cells. Nature. 2015;517(7534):293–301.
  • Brown TA, Lee JW, Holian A, et al. Alterations in DNA methylation corresponding with lung inflammation and as a biomarker for disease development after MWCNT exposure. Nanotoxicology. 2016;10(4):453–461.
  • Ehrlich M. DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics. 2019;14(12):1141–1163.
  • Issa J-P. Aging and epigenetic drift: a vicious cycle. J Clin Invest. 2014;124(1):24–29.
  • Nunes SP, Diniz F, Moreira-Barbosa C, et al. Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies. J Clin Med. 2019;8(9):1500.
  • Gunasekara CJ, Scott CA, Laritsky E, et al. A genomic atlas of systemic interindividual epigenetic variation in humans. Genome Biol. 2019;20(1):105.
  • Bonné S, Gilbert B, Hatzfeld M, et al. Defining desmosomal plakophilin-3 interactions. J Cell Biol. 2003;161(2):403–416.
  • Dusek RL, Attardi LD. Desmosomes: new perpetrators in tumour suppression. Nat Rev Cancer. 2011;11(5):317–323.
  • Hatzfeld M, Wolf A, Keil R. Plakophilins in desmosomal adhesion and signaling. Cell Commun Adhes. 2014;21(1):25–42.
  • Hofmann I, Casella M, Schnölzer M, et al. Identification of the junctional plaque protein plakophilin 3 in cytoplasmic particles containing RNA-binding proteins and the recruitment of plakophilins 1 and 3 to stress granules. Mol Biol Cell. 2006;17(3):1388–1398.
  • Schmidt A, Langbein L, Prätzel S, et al. Plakophilin 3 – a novel cell-type-specific desmosomal plaque protein. Differentiation. 1999;64(5):291–306.
  • Adam D, Roux-Delrieu J, Luczka E, et al. Cystic fibrosis airway epithelium remodelling: involvement of inflammation. J Pathol. 2015;235(3):408–419.
  • Besnard V, Dagher R, Madjer T, et al. Identification of periplakin as a major regulator of lung injury and repair in mice. JCI Insight. 2018;3(5). DOI:10.1172/jci.insight.90163
  • Müller L, Rietscher K, Keil R, et al. Plakophilin 3 phosphorylation by ribosomal S6 kinases supports desmosome assembly. J Cell Sci. 2020;133:8.
  • Breuninger S, Reidenbach S, Sauer CG, et al. Desmosomal plakophilins in the prostate and prostatic adenocarcinomas: implications for diagnosis and tumor progression. Am J Pathol. 2010;176(5):2509–2519.
  • Demirag GG, Sullu Y, Yucel I. Expression of Plakophilins (PKP1, PKP2, and PKP3) in breast cancers. Med Oncol. 2012;29(3):1518–1522.
  • Takahashi H, Nakatsuji H, Takahashi M, et al. Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer. Urology. 2012;79(1):240.e241–248.
  • Valladares-Ayerbes M, Diaz-Prado S, Reboredo M, et al. Evaluation of plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1432–1440.
  • Furukawa C, Daigo Y, Ishikawa N, et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 2005;65(16):7102–7110.
  • Sklyarova T, Bonne S, D’Hooge P, et al. Plakophilin-3-deficient mice develop hair coat abnormalities and are prone to cutaneous inflammation. J Invest Dermatol. 2008;128(6):1375–1385.
  • Sklyarova T, van Hengel J, Van Wonterghem E, et al. Hematopoietic plakophilin-3 regulates acute tissue-specific and systemic inflammation in mice. Eur J Immunol. 2015;45(10):2898–2910.
  • Chae YK, Choi WM, Bae WH, et al. Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer. Sci Rep. 2018;8(1):1023.
  • Bruscia EM, Bonfield TL. Innate and Adaptive Immunity in Cystic Fibrosis. Clin Chest Med. 2016;37(1):17–29.
  • Borghese B, Barbaux S, Mondon F, et al. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol. 2010;24(9):1872–1885.
  • Dyson MT, Roqueiro D, Monsivais D, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014;10(3):e1004158.
  • Toiyama Y, Okugawa Y, Kondo S, et al. Comprehensive analysis identifying aberrant DNA methylation in rectal mucosa from ulcerative colitis patients with neoplasia. Oncotarget. 2018;9(69):33149–33159.
  • Li L, Wei J, Li S, et al. The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation. EBioMedicine. 2019;45:553–562.
  • Horne DJ, Randhawa AK, Chau TT, et al. Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J Infect Dis. 2012;205(4):586–594.
  • Blanchard AC, Waters VJ. Microbiology of Cystic Fibrosis Airway Disease. Semin Respir Crit Care Med. 2019;40(6):727–736.
  • Françoise A, Héry-Arnaud G. The Microbiome in Cystic Fibrosis Pulmonary Disease. Genes (Basel). 2020;11(5):536.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.